Clinical Trial

Tfh Dysfunction in HIV and Aging

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this research is to evaluate blood samples from HIV infected and non-HIV infected people to understand how aging and HIV infection affect the immune responses (body defenses against infection) to the flu vaccine.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06-30 -> 2027-04-30 2026-07-19
minor Completion pushed: 2026-12-30 -> 2027-12-30 2026-07-19
Trial Details
NCT Number NCT04487041
Lead Sponsor University of Miami
Conditions Human Influenza
Enrollment 400 participants
Start Date 2020-10-30
Primary Completion 2027-04-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-17